HUM vs UNH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HUM · Humana$390.00 ▲ 2.63%
UNH · UnitedHealth$339.85 ▲ 2.84%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HUM +72.0%
- UNH +8.7%
Head to head
| Metric | HUM | UNH |
|---|---|---|
| Price | $390.00 | $339.85 |
| Change today | ▲ 2.63% | ▲ 2.84% |
| Market cap | $46.84B | $304.51B |
| Return, 3 months | +0.9% | -14.8% |
| Return, year to date | +53.4% | +4.3% |
| Return, 1 year | +73.6% | +8.4% |
| P/E (TTM) | 38.0 | 19.4 |
| P/B | 2.5 | 3.1 |
| P/E percentile vs own 5y | 95th | 41st |
| Dividend yield | 0.68% | 2.67% |
| Revenue growth (YoY, latest qtr) | +26.1% | -0.4% |
| Net profit growth (YoY) | -17.0% | +69.1% |
| Gross margin | – | 19.8% |
| Operating margin | – | 5.3% |
| Net margin | 0.8% | 3.5% |
| Return on equity | 6.7% | 16.4% |
| Analyst target vs. price | +31.9% | +42.6% |
| Analyst buy share | 76% | 88% |
| RSI (14) | 41 | 30 |
| 30-day volatility | 53.2% | 47.6% |
| Max drawdown, 1 year | -42.4% | -26.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UNH is the largest of the group by market value.
- HUM has returned the most over the past year.
- UNH carries the lowest trailing P/E.
- UNH pays the highest dividend yield.
- HUM is growing revenue fastest.
- UNH keeps the most profit per dollar of sales.
- UNH has been the calmest stock over the last 30 days.